Adverse events120

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 120

Type	Event	Organ system	Group	Affected	At risk
other	Abdominal pain	Gastrointestinal disorders	Tesamorelin (Double-blind Phase)	1	31
other	Abdominal pain	Gastrointestinal disorders	Placebo (Double-blind Phase)	2	30
other	Abdominal pain	Gastrointestinal disorders	Open Label Tesamorelin Arm	0	43
other	Alanine aminotransferase increased	Investigations	Tesamorelin (Double-blind Phase)	7	31
other	Alanine aminotransferase increased	Investigations	Placebo (Double-blind Phase)	5	30
other	Alanine aminotransferase increased	Investigations	Open Label Tesamorelin Arm	4	43
other	Alkaline phosphatase increased	Investigations	Tesamorelin (Double-blind Phase)	3	31
other	Alkaline phosphatase increased	Investigations	Placebo (Double-blind Phase)	0	30
other	Alkaline phosphatase increased	Investigations	Open Label Tesamorelin Arm	2	43
other	Arthralgia	Musculoskeletal and connective tissue disorders	Tesamorelin (Double-blind Phase)	3	31
other	Arthralgia	Musculoskeletal and connective tissue disorders	Placebo (Double-blind Phase)	3	30
other	Arthralgia	Musculoskeletal and connective tissue disorders	Open Label Tesamorelin Arm	1	43
other	Aspartate aminotransferase increased	Investigations	Tesamorelin (Double-blind Phase)	3	31
other	Aspartate aminotransferase increased	Investigations	Placebo (Double-blind Phase)	2	30
other	Aspartate aminotransferase increased	Investigations	Open Label Tesamorelin Arm	3	43
other	Cellulitis	Infections and infestations	Tesamorelin (Double-blind Phase)	0	31
other	Cellulitis	Infections and infestations	Placebo (Double-blind Phase)	1	30
other	Cellulitis	Infections and infestations	Open Label Tesamorelin Arm	2	43
other	Fall	Injury, poisoning and procedural complications	Tesamorelin (Double-blind Phase)	1	31
other	Fall	Injury, poisoning and procedural complications	Placebo (Double-blind Phase)	2	30

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02196831/events

API reference For AI assistants

Adverse events120

Sources 3

Read this list from software.